BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation
-
Published:2019-10
Issue:
Volume:138
Page:105039
-
ISSN:0928-0987
-
Container-title:European Journal of Pharmaceutical Sciences
-
language:en
-
Short-container-title:European Journal of Pharmaceutical Sciences
Author:
Rathod Drishti,
Fu Yige,
Patel KetanORCID
Subject
Pharmaceutical Science
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献